{
    "organizations": [],
    "uuid": "215751c316855981b192fc3871c9434e979ed423",
    "author": "",
    "url": "https://www.reuters.com/article/brief-kala-pharmaceuticals-posts-q4-loss/brief-kala-pharmaceuticals-posts-q4-loss-per-share-0-46-idUSASC09TKD",
    "ord_in_thread": 0,
    "title": "BRIEF-Kala Pharmaceuticals Posts Q4 Loss Per Share $0.46",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26, 2018 / 11:45 AM / Updated 11 minutes ago BRIEF-Kala Pharmaceuticals Posts Q4 Loss Per Share $0.46 Reuters Staff March 26 (Reuters) - Kala Pharmaceuticals Inc: * KALA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS * Q4 LOSS PER SHARE $0.46 * Q4 EARNINGS PER SHARE VIEW $-0.37 â€” THOMSON REUTERS I/B/E/S * ENDED 2017 WITH $114.6 MILLION IN CASH * PDUFA TARGET ACTION DATE FOR INVELTYS IS AUGUST 24, 2018 Source text for Eikon: Further company coverage:",
    "published": "2018-03-26T14:43:00.000+03:00",
    "crawled": "2018-03-26T15:04:08.045+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "post",
        "q4",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "march",
        "reuters",
        "kala",
        "pharmaceutical",
        "inc",
        "kala",
        "pharmaceutical",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "ended",
        "million",
        "cash",
        "pdufa",
        "target",
        "action",
        "date",
        "inveltys",
        "august",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}